These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32683185)

  • 1. Hemorrhagic encephalopathy associated with COVID-19.
    Krett JD; Jewett GAE; Elton-Lacasse C; Fonseca K; Hahn C; Au S; Koch MW
    J Neuroimmunol; 2020 Jul; 346():577326. PubMed ID: 32683185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
    Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
    J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.
    Pilotto A; Masciocchi S; Volonghi I; De Giuli V; Caprioli F; Mariotto S; Ferrari S; Bozzetti S; Imarisio A; Risi B; Premi E; Benussi A; Focà E; Castelli F; Zanusso G; Monaco S; Stefanelli P; Gasparotti R; Zekeridou A; McKeon A; Ashton NJ; BlennoW K; Zetterberg H; Padovani A
    Clin Infect Dis; 2021 Nov; 73(9):e3019-e3026. PubMed ID: 33395482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first case of hemorrhagic shock and encephalopathy syndrome with fulminant hypercytokinemia associated with pediatric COVID-19.
    Kurane K; Wakae K; Yamagishi H; Kawahara Y; Ono M; Tamura D; Furuya K; Taga N; Matsuki M; Yamagata T; Muramatsu K
    Brain Dev; 2024 Jan; 46(1):44-48. PubMed ID: 37730452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine release syndrome-associated encephalopathy in patients with COVID-19.
    Perrin P; Collongues N; Baloglu S; Bedo D; Bassand X; Lavaux T; Gautier-Vargas G; Keller N; Kremer S; Fafi-Kremer S; Moulin B; Benotmane I; Caillard S
    Eur J Neurol; 2021 Jan; 28(1):248-258. PubMed ID: 32853434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke.
    Pensato U; Muccioli L; Pasini E; Tappatà M; Ferri L; Volpi L; Licchetta L; Battaglia S; Rossini G; Bon I; Re MC; Cirillo L; Simonetti L; Gramegna LL; Michelucci R; Cortelli P; Zini A; Bisulli F
    Front Neurol; 2020; 11():587226. PubMed ID: 33193051
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of Neurological Manifestations of SARS-CoV-2.
    Priyal ; Sehgal V; Kapila S; Taneja R; Mehmi P; Gulati N
    Cureus; 2023 Apr; 15(4):e38194. PubMed ID: 37257164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study.
    Kasai M; Sakuma H; Abe Y; Kuki I; Maegaki Y; Murayama K; Murofushi Y; Nagase H; Nishiyama M; Okumura A; Sakai Y; Tada H; Mizuguchi M; Takanashi JI;
    J Neurol Sci; 2024 Feb; 457():122867. PubMed ID: 38199023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
    Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
    Front Immunol; 2022; 13():866153. PubMed ID: 35479062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 encephalopathy: Clinical and neurobiological features.
    Uginet M; Breville G; Assal F; Lövblad KO; Vargas MI; Pugin J; Serratrice J; Herrmann FR; Lalive PH; Allali G
    J Med Virol; 2021 Jul; 93(7):4374-4381. PubMed ID: 33782993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.
    Benameur K; Agarwal A; Auld SC; Butters MP; Webster AS; Ozturk T; Howell JC; Bassit LC; Velasquez A; Schinazi RF; Mullins ME; Hu WT
    Emerg Infect Dis; 2020 Sep; 26(9):2016-2021. PubMed ID: 32487282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.
    Massa F; Vigo T; Bellucci M; Giunti D; Emanuela MM; Visigalli D; Capodivento G; Cerne D; Assini A; Boni S; Rizzi D; Narciso E; Grisanti GS; Coco E; Uccelli A; Schenone A; Franciotta D; Benedetti L
    Neurol Sci; 2024 Mar; 45(3):849-859. PubMed ID: 38169013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral Hemorrhage and Reversible Cerebral Vasoconstriction Syndrome in a Patient With COVID-19.
    Srinivasan A; Wilson BC; Bear M; Hasan A; Ezzeldin O; Alim S; Elfallal S; Fang X; Ezzeldin M
    Cureus; 2021 Aug; 13(8):e17408. PubMed ID: 34589319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
    Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
    Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG
    Front Immunol; 2023; 14():1170012. PubMed ID: 37063871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.